Japan's snap election announcement and persistent US goldilocks economic data drove market movements last week. China's measured stimulus approach and escalating geopolitical tensions shaped commodity markets. Bank of Japan decision ahead.
A notable divergence has emerged within US equities as mega-cap stocks retreat from recent peaks whilst smaller companies demonstrate catch-up momentum. This trend becomes evident when comparing the S&P 500 index performance against the S&P 500 equal-weight index—the former declined 0.4% whilst the latter advanced 0.7%. A similar pattern manifested between the Russell 2000 (+2.0%) and Nasdaq 100 (-0.9%).
Major banking institutions delivered robust results overall, buoyed by strong trading revenues, though investor scrutiny of individual report cards has driven performance divergence. Goldman Sachs' shares surged 4.6% following record-setting equity trading revenue—the highest for any Wall Street bank. Conversely, JPMorgan Chase's shares declined 4.2% on disappointing investment banking fees despite meeting overall top and bottom-line expectations.
The technology sector received support from Taiwan Semiconductor Manufacturing Company's (TSMC) results, as the chipmaker delivered 25.5% year-on-year (YoY) revenue growth in Q4 whilst raising long-term gross margin guidance to above 56%. The financial report alleviates concerns regarding the sustainability of artificial intelligence (AI) demand.
The US Tech 100 index encountered resistance level at the upper boundary of a two-month consolidation range near 25,830, a level that has persisted for nearly two months. The relative strength index (RSI) resumed its declining trajectory, indicating weakening momentum and suggesting the probability of establishing a new historical high remains limited in the near term. The index should find support around 24,650 and is likely to trade within a sideways range this week.
The Hang Seng Index (HSI) advanced 2.3% last week, closing at 26,845 on Friday and capping a volatile period characterised by strong early-week gains that were partially eroded by regulatory concerns and profit-taking.
Healthcare companies continued to lead gains. Alibaba Health surged 17.9% on optimism surrounding artificial intelligence applications in healthcare, buoyed by reports that AI health assistant "Ant Afu" exceeded 30 million monthly active users shortly after launch, validating substantial market demand for AI-powered health services. Parent company Alibaba also gained 13.5% following upgrades to its Qwen AI application.
Regulatory intervention tempered sentiment mid-week as authorities launched an antitrust investigation into Trip.com over alleged abuse of market dominance and monopolistic practices. The online travel platform plummeted 21.8% during the week. Separately, Pop Mart retreated 9.3% following a China Labor Watch report alleging serious labour violations at a key Labubu supplier.
Beijing also implemented tighter margin financing requirements effective 19 January, aiming to curb excessive leverage as mainland turnover reached record levels. Despite this cooling measure, the PBOC's signal that further reserve requirement ratio and policy rate reductions remain under consideration provided market support.
The HSI is currently establishing a foundation near 26,850 for its next advance towards the resistance zone around 27,000–27,300. The trend remains bullish as the 20-day simple moving average (SMA) has formed a golden cross with the 50-day SMA. The next rally phase would likely accelerate following three consecutive closes above 27,000. Any pullbacks should find support around 26,000.
The yen's weakness extended last week as the snap election may provide enhanced authority for the Takaichi administration to deploy larger fiscal expenditure whilst further delaying the Bank of Japan's (BOJ) policy normalisation trajectory. USD/JPY briefly touched 159.4, a level last observed on 12 July 2024 when the Japanese government deployed ¥3.2 trillion in currency support operations.
Finance Minister Katayama's emphatic warnings regarding sharp, unidirectional yen movements strengthens the case for potential currency intervention. However, despite the verbal guidance, no evidence of actual intervention has materialised even as USD/JPY approached the 158 level on multiple occasions since October.
Such interventions cannot be deployed arbitrarily given limited foreign exchange reserves and require coordination with fiscal and monetary policy to prove effective. Japan expended approximately $100 billion across four intervention operations in 2024 when USD/JPY approached 160. As of end-December 2025, Japan's foreign currency reserves stood at $1,164 billion. Markets currently price close to two additional BOJ rate increases in 2026, with the first likely occurring in the second half. Traders are growing impatient regarding central bank signalling; if the BOJ continues providing ambiguous guidance on the normalisation path, substantial downward pressure will accumulate on the yen.
An Elliott Wave pattern has emerged on USD/JPY's daily chart, where the advance since October aligns with Wave 5 under the framework. A 100% Fibonacci extension of Wave 3 could potentially drive USD/JPY to 162.8, though speculation regarding government intervention currently caps gains beyond 159. In the absence of intervention, USD/JPY is likely to consolidate between 156–157 before its next upward movement. Should the BOJ transmit clear signals of rate increases, this could trigger a retreat towards 154.5.
The upcoming week centres on China's economic performance, critical US inflation data and the BOJ's policy stance, alongside key corporate earnings that may influence sector sentiment.
China releases fourth-quarter gross domestic product (GDP) data on Monday, with markets anticipating growth deceleration to 4.4% YoY from the prior quarter's 4.8%. Despite the expected moderation, full-year growth remains on trajectory to meet Beijing's 5% target. Accompanying industrial production and retail sales figures will provide insights into whether additional stimulus measures are required to support the economy. Stronger-than-expected retail sales growth would signal improving domestic consumption dynamics, whilst industrial production figures will reveal whether the manufacturing sector's performance aligns with December's robust export growth, potentially confirming resilient external demand.
US monetary policy expectations will be shaped by Thursday's core personal consumption expenditure (PCE) index—the Fed's preferred inflation gauge. Following last week's benign CPI and PPI readings, markets will scrutinise the PCE data for confirmation that inflationary pressures continue moderating ahead of the Fed's January meeting.
The BOJ convenes Friday with interest rates expected to remain at 0.75%. Markets will closely analyse forward guidance for clarity on the policy trajectory. Governor Ueda's communication will prove crucial, as failure to provide conviction regarding future monetary tightening could intensify selling pressure on the yen, which has weakened substantially in recent sessions. Japanese inflation data released earlier that morning will inform the policy discussion.
On the corporate front, investors are keen to assess Netflix's capital allocation strategy following its announcement to acquire Warner Bros' studio operations. Intel's turnaround narrative will also draw considerable attention as the semiconductor manufacturer seeks to expand its foundry market share with its new product portfolio.
(in local exchange time)
Source: Trading Economics, Nasdaq, LSEG (as of 18 January 2026)
This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients.